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Tumour necrosis factor receptor 1 (TNFR1)-activated TNFa reverse signal-
ling, in which membrane-integrated TNFa functions as a receptor for
TNFR1, enhances axon growth from developing sympathetic neurons and
plays a crucial role in establishing sympathetic innervation. Here, we have
investigated the link between TNFa reverse signalling and axon growth in
cultured sympathetic neurons. TNFR1-activated TNFa reverse signalling
promotes Ca2þ influx, and highly selective T-type Ca2þ channel inhibitors,
but not pharmacological inhibitors of L-type, N-type and P/Q-type Ca2þ
channels, prevented enhanced axon growth. T-type Ca2þ channel-specific
inhibitors eliminated Ca2þ spikes promoted by TNFa reverse signalling in
axons and prevented enhanced axon growth when applied locally to
axons, but not when applied to cell somata. Blocking action potential gener-
ation did not affect the effect of TNFa reverse signalling on axon growth,
suggesting that propagated action potentials are not required for enhanced
axon growth. TNFa reverse signalling enhanced protein kinase C (PKC) acti-
vation, and pharmacological inhibition of PKC prevented the axon growth
response. These results suggest that TNFa reverse signalling promotes open-
ing of T-type Ca2þ channels along sympathetic axons, which is required for
enhanced axon growth.1. Introduction
A variety of extracellular signals participate in regulating the establishment of
sympathetic innervation in the developing peripheral nervous system [1,2].
The most extensively studied and best understood of these is nerve growth
factor (NGF), a secreted protein synthesized in tissues innervated by NGF-
responsive neurons. NGF promotes the survival of developing sympathetic
neurons, and level of NGF synthesis in different tissues regulates the number
of neurons that innervate these tissues by restricting the extent of cell death
among the innervating neurons during development [3]. NGF also acts on sym-
pathetic axon terminals within target tissues to promote growth and branching
[4]. Whereas retrograde PI3-kinase/Akt signalling to the cell body plays an
important role in mediating NGF-promoted survival, activation of ERK1/
ERK2 downstream of TrkA, the NGF receptor tyrosine kinase, plays a major
role in mediating the local axon growth-promoting effects of NGF [5–8].
A recently discovered target-derived signal that also promotes sympathetic
axon growth and branching during the stage in development when sympathetic
axons are ramifying in their targets is tumour necrosis factor receptor 1
(TNFR1) [9]. TNFR1 expressed by sympathetic target tissues acts as a ligand
for membrane-integrated TNFa expressed along sympathetic axons, and
TNFR1-activated TNFa reverse signalling enhances sympathetic axon growth
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greatly reduced sympathetic innervation density in multiple
tissues, but unlike NGF-deficient mice, these mice show no
deficits in sympathetic neuron number. As with NGF,
activation of ERK1/ERK2 signalling plays a key role in med-
iating the axon growth-promoting effects of TNFa reverse
signalling. Activation of ERK1/ERK2 by TNFa reverse
signalling is due to rapid Ca2þ influx [9]; however, the iden-
tity of the channels that open in response to TNFa reverse
signalling is not known. Our aim here was to identify these
channels, determine where on sympathetic neurons they are
functionally relevant for axon growth in response to
TNFR1-activated TNFa reverse signalling, and provide a
link between Ca2þ influx and ERK1/ERK2 activation.
Using a combination of pharmacological studies, electro-
physiology, Ca2þ reporter studies and western blot analysis,
we show that activation of TNFa reverse signalling in sym-
pathetic axons increases T-type Ca2þ channel activation and
the subsequent activation of protein kinase C (PKC) and
ERK1/ERK2 are required for enhanced axon growth.2. Results
2.1. T-type Ca2þ channels are required for TNFR1-Fc-
promoted axon growth
Our demonstration that activation of TNFa reverse signalling
causes Ca2þ influx in postnatal sympathetic neurons and that
this is necessary for enhanced axon growth [9] implicates
ligand or voltage-gated Ca2þ channels in the axon growth
response to TNFR1. To examine this, we first tested whether
the broad-spectrum voltage-gated Ca2þ channel blocker
dotarizine [10,11] inhibits the growth response to TNFa
reverse signalling. Low density dissociated cultures of
superior cervical ganglion (SCG) neurons were plated in
medium containing NGF to sustain their survival and were
treated with a divalent TNFR1-Fc chimera to activate TNFa
reverse signalling [9] in the presence and absence of dotari-
zine. After 24 h, quantification of the size and complexity of
the neurite arbours showed that the TNFR1-Fc chimera
caused highly significant increases in neurite length and
branch point number (figure 1). Accordingly, the Sholl
profiles, which plot neurite intersections with a series of
concentric circles centred on the cell body, were clearly
larger and more complex than those for neurons grown
with NGF alone (control cultures). The size and complexity
of the neurite arbours of neurons treated with dotarizine
alone were not significantly different from those in control
cultures. However, 1 mM dotarizine completely prevented
TNFR1-Fc enhanced neurite growth (figure 1). These studies
suggest that voltage-gated Ca2þ channels at the plasma mem-
brane are required for the axon growth enhancing effect of
TNFa reverse signalling.
To ascertain which kinds of voltage-gated Ca2þ channels
are required for the enhanced axon growth response to TNFa
reverse signalling, we carried out similar studies using sub-
type-selective Ca2þ channel blockers [12]. For these
experiments, we used 10 mM nifedipine which is a selective
blocker of L-type Ca2þ channels [13], 100 nM v-agatoxin
TK which blocks P/Q-type Ca2þ channels, [14], 10 nM
v-grammotoxin SIA which blocks N-type and P/Q-type
Ca2þ channels [15,16], 60 nM SNX 482 which blocks R-typeCa2þ channels [17] and several T-type Ca2þ channel blockers,
1 mM mibefradil [18–20], 200 nM TTA-A2 [21] and 200 nM
TTA-P2 [22]. None of these Ca2þ channel inhibitors had
any significant effect on the extent of NGF-promoted axon
growth from P0 SCG neurons when added in the absence
of TNFR1-Fc (figures 1 and 2). None of the blockers nifedi-
pine, v-agatoxin TK, v-grammotoxin SIA or SNX 482
significantly affected TNFR1-Fc-enhanced axon growth
(figure 1), suggesting that none of the L-type, N-type, P/Q-
type or R-type Ca2þ channels are required for the enhanced
axon growth response to TNFR1-Fc. However, each of the
T-type Ca2þ channel blockers (mibefradil, TTA-A2 and
TTA-P2) completely inhibited TNFR1-Fc-enhanced axon
growth (figure 2a,b). None of these T-type Ca2þ channel
blockers significantly affected neuronal survival either alone
or in the presence of TNFR1-Fc at the concentrations used
(not shown). These findings suggest that T-type Ca2þ
channels are required for TNFR1-enhanced axon growth.
2.2. Expression of T-type Ca2þ channel mRNA in
developing superior cervical ganglion neurons
TNFa reverse signalling enhances axon growth from SCG
neurons during a narrow developmental window between
P0 and P5 when sympathetic axons are ramifying extensively
in their targets [9]. To confirm expression of transcripts
encoding T-type Ca2þ channels in SCG during this period
of development, we used real-time PCR to quantify the
levels of mRNAs encoding these channels in SCG dissected
from mice at stages from E18 to P10. Separate genes,
Cav3.1, Cav3.2 and Cav3.3, encode three T-type Ca
2þ channel
isoforms that are all low voltage-activated and inactivating,
but differ slightly in their biophysical properties and distri-
bution [23]. Real-time PCR revealed that transcripts for all
three genes are expressed throughout this period of develop-
ment (figure 2c). There was an overall decrease in level of
Cav3.1 mRNA with developmental age and the expression
of Cav3.2 and Cav3.3 mRNAs peaked at P0 (figure 2c).
These results are consistent with the expression of all three
T-type Ca2þ channel isoforms throughout the period of
development when TNFa reverse signalling enhances axon
growth.
2.3. T-type Ca2þ currents are undetectable in superior
cervical ganglion somata
Given our evidence for the involvement of T-type Ca2þ chan-
nels in mediating the effects of TNFa reverse signalling on
axon growth, we recorded Ca2þ currents from SCG neuron
somata using whole cell patch clamp (figure 3). T-type
channels are activated at low potentials (around –40 mV),
and the current generated is characterized by a rapid acti-
vation and a rapid inactivation [23]. We initially recorded
voltage-gated Ca2þ currents in response to a test potential
to 25 mV from a holding potential of 280 mV using 5 mM
Ca2þ as a charge carrier; in these conditions, T-type Ca2þ
channels should be maximally activated with a reduced
contribution of high voltage-activated Ca2þ current. Ca2þ
currents were recorded for 5 min before applying TNFR1-Fc
and then recorded every 10 s for 10–15 min (figure 3a).
In control conditions, Ca2þ currents exhibited only a sus-
tained, non-inactivating, component characteristic of high
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Figure 1. Voltage-sensitive Ca2þ channels other than L-, N-, P/Q- and R-type are required for TNFR1-Fc-promoted neurite growth. Bar charts of length and branch
point number and the Sholl profiles of P0 SCG neurons cultured for 24 h with either 10 ng ml21 NGF alone (control), NGF and 10 ng ml21 TNFR1-Fc, NGF and
calcium channel blocker or NGF, TNFR1-Fc and calcium channel blocker. Data from experimental series using the blockers as indicated: 1 mM dotarizine, 10 mM
nifedipine, 100 nM v-agatoxin TK, 10 nM v-grammotoxin SIA and 60 nM SNX 482. The mean+ s.e.m. of neurite arbour data of at least 150 neurons per
condition combined from three separate experiments of each type are shown (***p , 0.001, **p, 0.01, *p, 0.05, statistical comparison with control).
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Figure 2. Blocking T-type Ca2þ channels inhibits TNFR1-Fc-promoted neurite growth. (a) Representative camera lucida drawings of P0 SCG neurons cultured for
24 h with either 10 ng ml21 NGF alone, NGF and 10 ng ml21 TNFR1-Fc or NGF, TNFR1-Fc and a T-type Ca2þ channel blocker (1 mM mibefradil, 200 nM TTA-A2
and 200 nM TTA-P2). Scale bar, 100 mm. (b) Bar charts of length and branch point number and the Sholl profiles of P0 SCG neurons cultured for 24 h with either
NGF alone (control), NGF plus TNFR1-Fc, NGF plus a T-type Ca2þ channel blocker (as indicated) or NGF, TNFR1-Fc and a T-type Ca2þ channel blocker. Mean+
s.e.m. of neurite arbour data of at least 150 neurons per condition combined from three separate experiments of each type, ***p , 0.001, **p , 0.01, *p, 0.05,
statistical comparison with control. (c) Levels of Cav3.1, Cav3.2 and Cav3.3 mRNAs relative to reference mRNAs in SCG of different ages. The data are normalized to a
value of 1.0 at the E18 data. Mean+ s.e.m. of data from four separate sets of ganglia at each age are shown.
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Fc, Ca2þ currents were similar in shape and amplitude
(figure 3a,b). In order to maximize the size of the currents,
we raised the Ca2þ concentration in the recording medium
to 10 mM, and we compared the current–voltagerelationships of the Ca2þ currents before and after treatment
with TNFR1-Fc (figure 3c,d). In these conditions, no low vol-
tage-activated transient Ca2þ current could be recorded after
applying TNFR1-Fc and no difference in the current–voltage
curves was recorded. Altogether, our results suggest that
(c)
(a) (b)
(d)
250 pA 
10 ms 
–80 mV
–60 mV
+50 mV
+TNFR1 
control 
cu
rr
en
t a
m
pl
itu
de
(pe
rce
nta
ge
 of
 co
ntr
ol)
120
–40 0
0.2
0.4
0.6
0.8
1.0
1.2
40 80
100
80
60
40
20
0
co
ntr
ol
control
TN
FR
1-F
c
TNFR1-Fc
TNFR1-Fc 
25 ms 
25 pA
–80 mV
–5 mV
current amplitude
(normalized to control) 
( f )
(e)
(g)
*** *** 
NGF NGF 
NGF NGF 
TTA-P2 
NGF NGF 
TTA-P2l TNFR1-Fc 
NGF NGF 
TNFR1-Fc 
NGF NGF 
TTA-P2 + 
TNFR1-Fc    
TTA-P2 
NGF NGF 
cell
somas
axons
1000
800
600
400
200
co
ntr
ol
TN
R1
-Fc
 (ax
on)
TT
A-
P2
 (ax
on)
TT
A-
P2
 + 
TN
FR
1-F
c (a
xon
)
TT
A-
P2
 (so
ma
), T
NF
R1-
Fc 
(ax
on)
TT
A-
P2
 (so
ma
)
le
ng
th
 (m
m)
Figure 3. Functional significance of T-type Ca2þ channels in sympathetic axons. (a) Representative current traces resulting from a step potential from 280 mV to
25 mV before Fc fragment (control, black trace) and after 10–15 min application of TNFR1-Fc (5 mg ml21; red trace). Ca2þ currents were recorded every 10 s
before and after the application of TNFR1-Fc. Recordings were performed using 5 mM Ca2þ as a charge carrier. No clear difference in calcium current shape and
amplitude is visible between the control and the treatment with TNFR1 suggesting that no T-type currents are functionally expressed in the somata of SCG neurons.
(b) Bar chart shows the normalized peak Ca2þ current amplitude recorded from SCG neurons before (filled bar) and 10 to 15 min after starting TNFR1-Fc treatment
(open bar, 92+ 18%, n ¼ 7 cells, p ¼ 0.1328, paired t-test). (c) Representative current traces recorded from a TNFR1-treated SCG neuron in response to step
potentials from 280 mV to between 260 mV to þ50 mV in 10 mV increments. Recordings were performed using 10 mM Ca2þ as a charge carrier. (d ) Normal-
ized current–voltage relationship for calcium currents recorded from SCG neurons before (filled squares, n ¼ 10 cells) and after 15 min TNFR1-Fc application (open
circles, n ¼ 6 cells). The mean+ s.e.m. data are fitted with a modified Boltzmann function with V50,act of þ17.4+ 0.9 and þ16.2+ 0.5 mV, respectively, and
normalized Gmax of 2.5+ 0.2 and 2.2+ 0.2 nS pF
21, respectively. (e) Schematic illustration of the two-chamber microfluidic device. ( f ). Representative images of
calcein-AM labelled P0 SCG neurons that were cultured for 24 h in a two-compartment microfluidic device containing 10 ng ml21 NGF in both compartments, with
or without 10 ng ml21 TNFR1-Fc in the axon compartment and 200 nM TTA-P2 in either the axon or soma compartment, as indicated. Scale bar, 100 mm. (g) Bar
chart of mean axon length of neurons projecting axons into the axon compartment under the experimental conditions indicated (control ¼ NGF alone in both
compartments). The data represent the mean+ s.e.m. of nine independent experiments (***p, 0.001, statistical comparison with control).
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expression of T-type channels in the somata of SCG neurons.
2.4. T-type Ca2þ channels are functionally relevant
in sympathetic axons not in cell somata
The above results raise the possibility that T-type Ca2þ chan-
nels are only functionally relevant for axon growth
enhancement by TNFa reverse signalling along the axons
themselves. To test this, we blocked these channels in a com-
partment culture paradigm in which the cell somata and
growing axons are cultured in different compartments separ-
ated by a barrier (figure 3e). We previously reported that
addition of TNFR1-Fc to the axon compartment, but not to
the soma compartment, enhances axon growth [9]. Here we
studied the consequences of blocking T-type Ca2þ channels
separately in the soma and axon compartments on TNFR1-
Fc-enhanced axon growth. In these experiments, we seeded
P0 SCG neurons into one compartment (the soma compart-
ment) of a two-compartment device that contained NGF in
both compartments to sustain neuronal survival and encou-
rage axon growth from the soma compartment into the
axon compartment. After a 24 h incubation, we labelled the
axons in the axon compartment with the fluorescent vital
dye calcein-AM, which also retrogradely labelled cell bodies
of neurons that projected axons into the axon compartment.
We used a stereological method to quantify the extent of
axon growth in the axon compartment relative to the
number of neurons projecting axons into this compartment.
Addition of the T-type Ca2þ channel blocker TTA-P2 to
either the axon compartment or the soma compartment had
no significant effect on the extent of axon growth in the
axon compartment in cultures that were not treated with
TNFR1-Fc (figure 3f,g). Addition of TNFR1-Fc to the axon
compartment significantly enhanced axon growth in this
compartment. Enhanced axon growth was completely inhib-
ited by the addition of TTA-P2 to the axon compartment,
but not by TTA-P2 addition to the soma compartment
(figure 3f,g). Similar experiments using the T-type Ca2þ chan-
nel blocker mibefradil yielded very similar results (not
shown). These findings suggest that T-type Ca2þ channels
are functionally relevant for axon growth enhancement by
TNFa reverse signalling in axons, but not in somata.
2.5. TNFa reverse signalling induces Ca2þ transients in
sympathetic axons via T-type Ca2þ channels
To determine whether activation of TNFa reverse signalling
induces Ca2þ transients in sympathetic axons, P0 SCG neur-
ons were co-transfected with plasmids expressing mCherry
or DsRed (to identify transfected neurons) and a genetically
encoded Ca2þ sensor (GCaMP6s-CAAX) whose expression
is targeted to the plasma membrane [24]. After transfection,
the neurons were cultured for 12 h in medium containing
10 ng ml21 NGF and 300 nM TAPI-O (TNFa processing
inhibitor, which inhibits TACE and thereby maintains the
level of membrane-integrated TNFa at the plasma mem-
brane). Variations in fluorescence were then recorded in
processes, and growth cones of SCG neurons perfused with
a saline solution for 5 min before adding Fc fragment control
protein or TNFR1-Fc (figure 4a). Prior to treatment with these
reagents, there was a low frequency of Ca2þ transients. Whenanalysed at 5 min intervals after the start of treatment, the
signal frequency became significantly greater in TNFR1-
Fc-treated cultures compared with Fc-treated control cultures
between 5 and 10 min after the start of treatment, and
remained significantly greater at each subsequent 5 min inter-
val until the end of the recording period at 25 min (figure 4b).
Interestingly, Ca2þ transients were local events and did not
propagate to the rest of the neuron. These results suggest
that TNFR1-Fc increases the frequency of Ca2þ transients.
Integration of the areas under individual fluorescent peaks
above a standard threshold revealed significant increases in
TNFR1-Fc-treated cultures compared with Fc-treated cultures
during each 5 min interval, starting at the 5–10 min interval
(figure 4c). However, there was no significant increase in
the amplitude of individual Ca2þ transient peaks in
TNFR1-Fc-treated cultures compared with Fc-treated controls
(figure 4d ). Taken together, these results suggest that TNFR1-
Fc not only increases the frequency of Ca2þ signals but also
increases the duration of individual events. These significant
increases in both the frequency and duration of fluorescent
signals brought about by TNFR1-Fc were completely pre-
vented by TTA-P2 (figure 4b,c), suggesting that these events
were mediated by T-type Ca2þ channels. In addition to the
temporal characteristics of fluorescence signals, differences
were observed in their spatial distribution.
2.6. TNFR1-Fc-enhanced axon growth occurs
independently of action potential generation
Because activation of T-type Ca2þ channels has been shown
to trigger a burst of action potentials mediated by Naþ chan-
nels in many different kinds of neuron [23], we investigated
whether action potential generation plays a role in TNFRl-
Fc-promoted axon growth. To test this, we treated P0 SCG
neurons with tetrodotoxin (TTX), a selective blocker of most
voltage-gated Naþ channels and inhibitor of action potential
generation in neurons. TTX did not inhibit TNFR1-Fc-
promoted neurite growth, suggesting that the generation of
action potentials is not required for enhanced axon growth
(figure 5a). T-type channels are known to participate in low
threshold oscillations in other tissues [25].
2.7. Protein kinase C activation is required for TNFR1-
Fc-promoted axon growth
We have previously shown that TNFa reverse signalling
enhances axon growth by activating MEK/ERK of the MAP
kinase signalling cascade [9]. To elucidate the link between
T-type Ca2þ channels, Ca2þ influx, elevation of [Ca2þ]i and
MEK/ERK activation, we explored the potential role of
PKC, a family of serine–threonine protein kinases that has
been implicated in activating multiple signalling cascades,
including MAP kinase signalling [26–28]. Of the 10 known
PKC members, the conventional isozymes (PKC-a, PKC-bI,
PKC-bII and PKC-g) are activated by both [Ca2þ]i and diacyl-
glycerol [29]. We began our investigation of the potential role
of PKC in TNFR1-Fc-promoted axon growth by ascertaining
whether TNFR1-Fc activates PKC in cultured SCG neurons.
In these experiments, we first cultured P0 SCG neurons for
12 h with NGF before treating them with TNFR1-Fc. Western
blot analysis revealed an increase in the level of phosphoser-
ine 660 PKC-bII after 15 min exposure to TNFR1-Fc. This
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Figure 4. TNFR1-Fc promotes Ca2þ influx in sympathetic axons via T-type Ca2þ channels. (a) Micrographs of Ca2þ transients in neurites of SCG neurons co-trans-
fected with DsRed and GCaMP6s-CAAX, grown with 10 ng ml21 NGF and treated with either 5 mg ml21 Fc fragment (left panels) or 5 mg ml21 TNFR1-Fc (right
panels). The black and white panels in the Fc fragment-treated and TNFR1-Fc-treated neurons show transfected neurons expressing DsRed, which was used to
maintain focus during image acquisition. Red arrows indicate regions of interest in the axons (1, 2, 3 and 4 for Fc fragment-treated cells and 5, 6, 7 and 8
for TNFR1-Fc-treated cells). Scale bar, 50 mm. The pseudo colour scale between the panels indicates the GCaMP fluorescence intensity. Representative time courses
of the GCaMP fluorescence signal corresponding to individual regions of interest in Fc fragment-treated (1–4) or TNFR1-Fc-treated (5–8) neurons. DF/F0 corre-
sponds to the variation of fluorescence over the initial fluorescence and is expressed as an arbitrary unit. (b) Bar chart of the frequency of Ca2þ transients before and
after application of either 5 mg ml21 Fc fragment, 5 mg ml21 TNFR1-Fc or TNFR1-Fc plus 1 mM TTA-P2. Mean+ s.e.m. of data derived from 143 regions of
interest of 13 Fc-treated neurons, 235 regions of interest of 16 TNFR1-Fc-treated neurons and 216 regions of interest from 13 neurons treated with TNFR1-Fc plus
TTA-P2 from three separate experiments of each type. *p, 0.05 TNFR1-Fc-treated versus control, ***p, 0.001 TNFR1-Fc-treated versus control, Bonferroni’s
multiple comparison test. (c) Bar chart of the area under individual Ca2þ peaks in the same experiments. (d ) Bar chart of the peak amplitude in the same
experiments.
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mibefradil (figure 5b).
To determine whether PKC activation is required for
ERK1/ERK2 activation by TNFR1-Fc, we studied the effect
of GF 109203X, a potent and selective inhibitor of PKC [30].In these experiments, we first cultured P0 SCG neurons for
12 h with NGF before treating them with TNFR1-Fc. Western
blot analysis revealed that the increases in phospho-ERK1
and phospho-ERK2 brought about by TNFR1-Fc treatment
were partially or fully prevented by preincubating the
*** 
*** *** *** 
(a)
(b) (c)
(d)
*** 
*** 
phospho   
ERK1/2 
total  
ERK1/2 
TNFR1-Fc      –       +       –        +               
GF109203x    –       –       +        + 
b-III tubulin
37 
37 
50 
kDa  
50 
50 
** 
* 
TNFR1-Fc   –       +       –      +               
mibefradil     –        –       +       + 
Pser660-PKC
Total PKC
b-III tubulin 
kDa  
75 
75 
50 
co
ntr
ol
TN
FR
1fc
co
ntr
ol
TN
FR
1-F
c
GF
 10
920
3x
GF
 10
920
3x 
+
TN
FR
1-F
c co
ntr
ol
TN
FR
1-F
c
GF
 10
920
3x
GF
 10
920
3x 
+
TN
FR
1-F
c
control
TNFR1-Fc
GF 109203x
GF 109203x +
TNFR1-Fc
m
ibe
fra
dil
m
ibe
fra
di l
+
TN
FR
1fc
co
ntr
ol
TN
FR
1fc
GF
 10
92
03
x
GF
 10
92
03
x +
TN
FR
1fc
100 
100 
le
ng
th
 (m
m)
le
ng
th
 (m
m)
pP
K
C/
to
ta
l P
K
C 
(%
 co
ntr
ol)
pE
RK
/to
ta
l E
RK
 (%
 co
ntr
ol)
br
an
ch
in
g 
po
in
ts
br
an
ch
in
g 
po
in
ts
in
te
rs
ec
tio
ns
in
te
rs
ec
tio
ns
distance from soma (mm)con
tro
l
TN
FR
1-F
c
TT
X
TT
X +
 TN
FR
1-F
c
co
ntr
ol
TN
FR
1-F
c
TT
X
TT
X +
 TN
FR
1-F
c
6
4
2
0
120
6 20
16
12
8
4
0
0 150 300 450
distance from soma (µm)
600 750
16
12
8
4
0
4
2
0
100
80
60
220
pERK1/total ERK1
pERK2/total ERK2
180
140
60
100
0
3
6
9
12
15
18 14
12
10
8
6
4
2
0
0 150 300
control
TNFR1-Fc
TTX
TTX + TNFR1-Fc
450 600 750
*** 
*** 
Figure 5. TNFR1-Fc-enhanced axon growth occurs independently of action potential generation and the requirement for PKC activation. (a) Bar charts of length and
branch number and Sholl profiles of P0 SCG neurons cultured for 24 h with either 10 ng ml21 NGF alone (control), NGF and 10 ng ml21 TNFR1-Fc, NGF and 100 nM TTX
or NGF, TNFR1-Fc and TTX. Mean+ s.e.m of neurite arbour data of 150 neurons per condition combined from three separate experiments of each type (***p , 0.001,
statistical comparison with control). (b) Representative immunoblot probed for phospho-(Ser660) PKC, total PKC and b-III tubulin of lysates of P0 SCG neurons that were
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not significantly affect the levels of phospho-ERK1 and
phospho-ERK2 (figure 5c).
Finally, to investigate if PKC activation is required for
TNFR1-Fc-promoted neurite growth, we examined whether
GF 109203X could prevent this. In these experiments, we
plated P0 SCG neurons in NGF-containing medium, pre-
treated them for 2 h with GF 109203X before adding
TNFR1-Fc and imaging the neurite arbours 24 h later. GF
109203X prevented TNFR1-Fc enhanced neurite growth, as
shown by quantification of neurite length, branch point
number and Sholl analysis (figure 5d ). Taken together,
these findings suggest that PKC plays a role in mediating
the effect of TNFa reverse signalling on axon growth. l.7:1602883. Discussion
The data reported here establish the essential role of T-type
Ca2þ channels in mediating the effects of TNFa reverse sig-
nalling on axon growth in developing sympathetic neurons.
We show that each of three selective T-type Ca2þ channel
inhibitors, mibefradil, TTA-A2 and TTA-P2, completely pre-
vent TNFR1-Fc-promoted axon growth without affecting
axon growth in the absence of TNFR1-Fc or affecting
neuronal survival. In contrast, blockers of L-type, N-type,
P/Q-type and R-type Ca2þ channels have no effect on
TNFR1-Fc-promoted axon growth. Furthermore, we show
that TNFR1-Fc, but not Fc control protein, significantly
increases the frequency and duration of Ca2þ transients
recorded using a genetically encoded Ca2þ sensor targeted
to the plasma membrane, and that pharmacological blockade
of T-type Ca2þ channels completely prevents these increases.
Given the importance of Ca2þ influx and subsequent
elevation of intracellular Ca2þ to TNFR1-Fc-promoted axon
growth [9], our findings show that Ca2þ influx triggered by
activation of TNFa reverse signalling is mediated by T-type
Ca2þ channels and further support the crucial role of
T-type Ca2þ channels in TNFR1-Fc-promoted axon growth.
Our compartment culture results suggest that T-type
channels are only functionally relevant in axons for TNFR1-
promoted growth. TNFR1 only promoted axon growth
when applied to axons not somata and T-type Ca2þ channel
inhibitors only inhibited TNFR1-promoted axon growth
when applied to axons not somata. These results are consist-
ent with our whole-cell patch-clamp studies which did not
detect T-type Ca2þ currents at the somata. The absence of
T-type Ca2þ currents in the somata of sympathetic neurons,
as also shown in rat and frog SCG neurons [31–33], implies
that T-type Ca2þ channels are not expressed in this location
in sufficient numbers to be detected. T-type calcium channels
have only been identified in the cell bodies of a small subset
of sympathetic neurons [33]. This could be because these
Ca2þ channels migrate into axons as the neurons extend
axons in culture or because Ca2þ channels are synthesized
locally in axons because the encoding mRNA is transported
along axons prior to translation [34]. However, they were
not previously detected in developing axons or growth
cones of frog superior cervical neurons [33]. We detected
transcripts encoding all three T-type Ca2þ channel isoforms
in SCG throughout the period of development when TNFa
reverse signalling enhances axon growth. This raises the
possibility that all three subtypes could contribute to axongrowth, in the presence of TNFR1. Because subtype-specific
T-type Ca2þ channel inhibitors are not currently available,
we were unable to determine pharmacologically whether a
particular subtype plays a more prominent role than others.
While various anti-T-type channel antibodies have been
reported, they have questionable specificity for different
T-type Ca2þ channel isoforms and are thus of limited use
for immunocytochemical studies of the distribution of these
channel proteins.
Our imaging studies show that TNFa reverse signalling
modulates Ca2þ signalling by affecting the frequency and
duration of discrete events. TNFR1-Fc causes highly signifi-
cant increases in the frequency and duration of intracellular
Ca2þ transients and these increases are prevented from occur-
ring by T-type Ca2þ channel blockers. However, the T-type
channel blocker did not abolish these events under control
conditions, indicating that other Ca2þ channels are also
involved in these Ca2þ transients, and opening the possibility
that T-type channels were either inserted in the membrane by
TNFR1-Fc, or it caused a shift in the window current for
T-type channels [23], resulting in their increased availability
at the resting membrane potential in the axons.
An interesting issue is how TNFa reverse signalling influ-
ences the opening of T-type channels. It is well documented
that T-type Ca2þ channels open secondary to small mem-
brane depolarizations [23,35]. Thus, it is possible that TNFa
reverse signalling causes T-type Ca2þ channel opening by
first causing membrane depolarization. However, our current
clamp studies did not provide any evidence in support of
this in the cell body (data not shown). This raises the possi-
bility that TNFa reverse signalling only affects the
membrane potential in the developing sympathetic axons,
inducing oscillations, or affects T-type channels by another
means, for example by changing the voltage-dependence
of the window current, which is maximal at about 260 mV
in 2 mM Ca2þ [36]. There is evidence of numerous post-trans-
lational modifications of channels that affect T-type channel
properties [37,38].
In this study, we have demonstrated the crucial role of
T-type Ca2þ channels in mediating the effects of TNFa
reverse signalling on sympathetic axon growth. TNFa reverse
signalling has also been reported to enhance the growth of
sensory axons [39], which raises the question of whether
T-type Ca2þ channels play a role in sensory axon growth.
In addition to the effects of TNFa reverse signalling on
axon growth, an additional example of reverse signalling
within the TNF superfamily affecting axon growth has
recently been reported. CD40 ligand (CD40L, TNFSF5)
reverse signalling in subsets of sympathetic neurons enhances
axon growth, and this is required in vivo for the ramification
of axons in the tissues innervated by these neurons [40].
Again, it would be of interest to determine whether T-type
Ca2þ channels and Ca2þ influx play any role in mediating
CD40 L reverse signalling in developing sensory neurons,
where T-type channels have been identified in the somata
of specific subtypes [41,42], and play important physiological
and pathological roles [43].
We have previously shown that ERK1/ERK2 is activated
in developing sympathetic neurons by TNFR1-Fc and that
pharmacological inhibition of ERK1/ERK2 activation pre-
vents the axon growth response to TNFR1-Fc [9]. To
ascertain the link between TNFR1-Fc-promoted T-type Ca2þ
channel opening and ERK activation, we explored the
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activates in turn a variety of signalling pathways including
ERK [29]. We showed that TNFR1-Fc enhanced PKC acti-
vation and that pharmacological inhibition of PKC reduced
ERK1/ERK2 activation by TNFR1-Fc. Importantly, pharma-
cological inhibition of PKC completely prevented the axon
growth response of sympathetic neurons to TNFR1-Fc.
Taken together, our findings have established a sequence of
essential steps that link TNFa reverse signalling with
enhanced axon growth in developing sympathetic neurons.
Activation of TNFa reverse signalling enhances intracellular
Ca2þ transients mediated by T-type Ca2þ channels in axons,
leading to activation of PKC and activation of ERK1/ERK2.
In future work, it will be particularly interesting to establish
how TNFa reverse signalling modulates the opening of
T-type Ca2þ channels, initiating this chain of events.02884. Conclusion
We have discovered a novel and unexpected function for
voltage-gated T-type Ca2þ channels in axons of SCG sym-
pathetic neurons, which do not exhibit T-type channels in
their somata. We show that these channels mediate Ca2þ
transients in developing sympathetic axons following acti-
vation of TNF reverse signalling and that they are essential
for the enhanced axon growth and branching promoted by
TNF reverse signalling. Given the physiological significance
of TNF reverse signalling for establishing sympathetic inner-
vation, this constitutes a clear role for voltage-gated T-type
Ca2þ channels in sympathetic neuron development.5. Material and methods
5.1. Neuron culture
Dissected SCG were freed of adherent connective tissue using
tungsten needles and were trypsinized and plated at very low
density (approx. 200 neurons per dish/well) in polyornithine
and laminin-coated 35 mm tissue culture dishes (Greiner,
Gloucestershire, UK) or four-well dishes (Starlab, Milton
Keynes, UK) in serum-free Hams F14 medium [44] sup-
plemented with 0.25% Albumax I (Invitrogen, Paisley, UK).
Neuronal survival was estimated by counting the number
of neurons in four-well dishes 2 h after plating and again at
24 h. All neurons in each well were counted. The number of
neurons surviving at 24 h was expressed as a percentage of
the initial number of neurons counted. Analysis of the size
and complexity of neurite arbours was carried out in
35 mm dishes 24 h after plating. The neurite arbours were
labelled by incubating the neurons with the fluorescent
vital dye calcein-AM (1 : 1000, Invitrogen, Paisley, UK) at
the end of the experiment. Images of neurite arbours were
acquired by fluorescence microscopy and analysed to
obtain total neurite length, number of branch points and
Sholl profiles [45].
For studying the effects of regional blockade of T-type
Ca2þ channels on neurite growth, P0 SCG neurons were
plated in one compartment of a two-compartment microflui-
dic device (Xona microfludics, CA, USA). Both compartments
received NGF and the TNFR1-Fc was added to the axon com-
partment. A T-type Ca2þ channel blocker was added to either
the soma or axon compartment. After 24 h incubation, theaxons in the axon compartment and the cell bodies that pro-
jected axons into this compartment were labelled by adding
the fluorescent vital dye calcein-AM to the axon compart-
ment. Axon length was quantified by a modification of a
previously described method [46]. Briefly, using NIH
IMAGEJ, a grid of vertical lines was traced with an interline
interval of 200 mm. Total intersections between neurites and
the grid were counted and normalized against the number
of labelled somas in the cell body compartment. Average
neurite length per projecting cell body was calculated using
the formula L ¼ pDI/2, where L is the estimated length, D
is the interline interval and I the average number of intersec-
tions per projecting cell body. Measurements were
independently carried out in all fields along the microfluidic
barrier.
Purified recombinant NGF and TNFR1-Fc and caspase
inhibitor Q-VD-OPh were obtained from R&D Systems.
Dotarizine, v-agatoxin TK, v-grammotoxin SIA and mibe-
fradil were obtained from Santa Cruz Biotechnologies,
Heidelberg, Germany. Nifedipine was obtained from
Calbiochem, Watford, UK. SNX 482 and GF 109203x were
obtained from Tocris Biosciences, Abingdon, UK. TTA-A2
and TTA-P2 were obtained from Alomone, Jerusalem,
Israel. TTX was obtained from Abcam, Cambridge, UK.
TAPI-O was obtained from Enzo Life Sciences, Exeter, UK.5.2. GCaMP imaging in superior cervical ganglion
neurons
SCG neurons were co-transfected with either 0.8 mg
pCAGGs-mCherry (Addgene) or 0.8 mg pDsRed-Express-N1
(Clontech) and 2.5 mg membrane-directed pGPCMV-
GCaMP6s-CAAX (Addgene) using a microporator (Digital
Bio; 2  30 ms pulse at 900 V) and cultured at a high density
in medium containing 10 ng ml21 NGF and 300 nM TAPI-O
on glass coverslips that had been treated with polyornithine
and laminin. After 24 h, the coverslips were mounted in a
laminar-flow perfusion and stimulation chamber (Warner
Instruments) on the stage of an epifluorescence microscope
(Axiovert 200M, Zeiss). White and 470 nm LEDs served as
light sources (Cairn Research, UK). Fluorescence excitation
was done through an X20 0.75 NA Fluar Zeiss objective
using 470/40 nm and 572/35 nm excitation and 59022bs
dichroic filters (Chroma). Simultaneous acquisition of
GCaMP and mCherry/DsRed was performed using an
OptoSplit II (Cairn Research, UK) with 565 nm dichroic and
520/40 nm and 632/60 nm emission filters (Chroma).
GCaMP6 and mCherry/DsRed fluorescence was collected
at 1 Hz with an Andor iXonþ (model DU-897U-CS0-BV)
back-illuminated EMCCD camera using OPTOMORPH software
(Cairn Research, UK). An OptoMask (Cairn Research, UK)
was used to acquire two 512  256 pixel recordings of the
same field of view (one for GCaMP6 and one for mCherry/
DsRed). Cells were perfused (0.5 ml min21) in a saline
solution at 358C containing 119 mM NaCl, 2.5 mM KCl,
2 mM CaCl2, 2 mM MgCl2, 25 mM HEPES (buffered to pH
7.4) and 30 mM glucose for 5 min before the addition of
either 5 mg ml21 TNFR1-Fc or 5 mg ml21 human Fc-fragment
or 5 mg ml21 TNFR1-Fc þ 1 mM TTA-P2 for a further 25 min.
The last condition had an additional initial perfusion of 5 min
with 1 mM TTA-P2 alone. Transfected neurons were initially
identified by stimulating the preparation at 33 Hz for
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electrodes). Analysis was performed with IMAGEJ (http://
rsb.info.nih.gov/ij), using a custom-written plugin (http://
rsb.info.nih.gov/ij/plugins/time-series.html). Briefly, regions
of interest (ROI, 4 mm diameter circles) in the processes of
neurons were selected where rapid increases in GCaMP6 flu-
orescence occurred. Using the same threshold applied to all
ROI, the frequency of peaks above the threshold were calcu-
lated for each ROI, followed by the average peak amplitude
and the average area under the curve of the peaks.
5.3. Electrophysiological recordings
High density (50 000 neurons per 35 mm dish) SCG neuronal
cultures were used for electrophysiological experiments after
24 h in culture in medium containing 10 ng ml21 NGF and
300 nM TAPI-O (Enzo Life Sciences). Whole-cell patch-
clamp recordings were performed at room temperature
(21–258C) before and after the addition of 5 mg ml21
TNFR1-Fc or 5 mg ml21 human Fc fragment (Abcam) for
10–15 min. Single cells were voltage clamped using an Axo-
patch 200B patch-clamp amplifier (Axon instruments). Patch
pipettes were filled with a solution containing the following
(in mM): 140 Cs-aspartate, 5 EGTA, 2 MgCl2, 0.1 CaCl2,
2 K2ATP and 10 HEPES, titrated to pH 7.2 with CsOH. The
external solution contained the following: 150 mM tetra-
ethylammonium bromide, 3 mM KCl, 1 mM NaHCO3,
1 mM MgCl2, 10 mM HEPES, 4 mM glucose and 5 or
10 mM CaCl2, pH adjusted to 7.4 with Tris base. Measure-
ment and analysis were performed as previously described
[47]. Normalized current–voltage relationships were fitted
with a modified Boltzmann equation as follows: I ¼ Gmax 
(V 2 Vrev)/(1 þ exp( 2 (V2 V50,act)/k)), where I is the cur-
rent density (in picoamperes  picofarad21), Gmax is the
maximum conductance (in nanosiemens  picofarad21),
Vrev is the reversal potential in mV, V50,act is the midpoint
voltage for current activation in mV, and k is the slope factor.
5.4. Real-time QPCR
The levels of Cav3.1, Cav3.2 and Cav3.3 mRNAs were quan-
tified by RT-QPCR relative to a geometric mean of mRNAs
for the housekeeping enzymes glyceraldehyde phosphate
dehydrogenase (GAPDH), succinate dehydrogenase
(SDHA) and hypoxanthine phosphoribosyltransferase 1
(HPRT1). Total RNA was extracted from whole SCG with
the RNeasy Mini extraction kit (Qiagen, Crawely, UK), and
5 ml was reverse transcribed for 1 h at 458C using the Affinity-
Script kit (Agilent, Berkshire, UK) in a 25 ml reaction
according to the manufacturer’s instructions. cDNA (2 ml)
was amplified in a 20 ml reaction volume using Brilliant III
ultrafast QPCR master mix reagents (Agilent, Berkshire,
UK). QPCR products were detected using dual-labelled
(FAM/BHQ1) hybridization probes specific to each of the
cDNAs (MWG/Eurofins, Ebersberg, Germany). The PCR
primers were: gapdh forward 50-GAG AAA CCT GCC AAG
TAT G-30 and reverse 50-GGA GTT GCT GTT GAA GTC-30;
sdha forward 50-GGA ACA CTC CAA AAA CAG-30 and
reverse 50-CCA CAG CAT CAA ATT CAT-30; hprt1 forward
50-TTA AGC AGT ACA GCC CCA AAA TG-30 and reverse
50-AAG TCT GGC CTG TAT CCA ACA C-30; Cav3.1 forward
50-CTG GTT ATT CTC CTC AAC T-30 and reverse 50-TTCCCA AAG ATA CCC AAA-30; Cav3.2 forward 50-TGC TTC
TTC GTC TTC TTC-30 and reverse 50-CAG ATG AAT GGG
TTC TCC-30; Cav3.3 forward 50-CAT TGG AAA CAT TGT
CCT C-30 and reverse 50-CAG TGA TAG AAC TTG CCT-30.
Dual labelled probes were: gapdh, FAM-AGA CAA CCT
GGT CCT CAG TGT-BHQ1; sdha, FAM-CCT GCG GCT
TTC ACT TCT CT-BHQ1; Hprt1, FAM-TCG AGA GGT
CCT TTT CAC CAG CAA G-BHQ1; Cav 3.1, FAM-CGA
CCA TCT TCA CCA CCA-BHQ1; Cav3.2, FAM-CCT CCT
CTG TCT GGT AGT ATG GC-BHQ1 and Cav3.3, FAM-
CGC CTT CTT CAT CAT CTT CGG T-BHQ1. Forward and
reverse primers were used at a concentration of 150 nM
each and dual-labelled probes were used at a concentration
of 300 nM. PCR was performed using the Mx3000P platform
(Agilent, Berkshire, UK) using the following conditions: 45
cycles of 958C for 12 s and 608C for 35 s. Standard curves
were generated in every 96-well plate, for each cDNA for
every real-time PCR run, by using serial threefold dilutions
of reverse transcribed spleen total RNA (Ambion, Paisley,
UK). Three separate dissections were performed for each age.5.5. Immunoblotting
For harvesting protein for western blot, neurons were cul-
tured at a high density (approx. 85 000 neurons per well) in
96-well plates. Immunoblotting was carried out using the
BioRad TransBlot (BioRad, Hertfordshire, UK) as previously
described [48]. The blots were probed with antibodies to
phospho-PKC (pan bII Ser660, 1 : 1000, Cell Signaling,
Hertfordshire, UK, catalogue number 9371), PKC (Millipore,
Watford, UK, catalogue number 05-983), phospho-ERK1/
ERK2 (1 : 1000, Cell Signaling, catalogue number 9101),
total ERK1/ERK2 (1 : 1000, Cell Signaling, catalogue
number 9102), b-III tubulin (1 : 10 000, R&D systems, Abing-
don, UK, catalogue number MAB119). Binding of the
primary antibodies was visualized with an HRP-conjugated
secondary antibody (1 : 2000; Promega, Southampton, UK)
and ECL-plus (Amersham, Buckinghamshire, UK). All
primary antibodies labelled bands of the expected sizes.5.6. Statistical analysis
Statistical comparisons were performed by independent
Student’s t-test or one-way ANOVA followed by Fisher’s
post hoc test.
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